Prasugrel Antiplatelet Efficacy Compared to Clopidogrel adjuSted Loading Doses in Patients With High Platelet Reactivity After Stenting

Trial Profile

Prasugrel Antiplatelet Efficacy Compared to Clopidogrel adjuSted Loading Doses in Patients With High Platelet Reactivity After Stenting

Completed
Phase of Trial: Phase III

Latest Information Update: 11 Sep 2015

At a glance

  • Drugs Clopidogrel (Primary) ; Prasugrel (Primary)
  • Indications Blood platelet disorders; Embolism and thrombosis
  • Focus Pharmacodynamics
  • Acronyms PECS-HPR
  • Most Recent Events

    • 01 Apr 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 19 Dec 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top